Evidence map›Paper›PMID 42598667›Full record

ArticleInflammatory intestinal diseases

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Talia Azad, Junaid Mushtaq, Ghias Un-Nabi Tayyab, Om Parkash, Maliha Aziz, Tauseef Ali, Muhammad Umair, Ali Syed Gillani, Muslim Atiq

Abstract read
In one paragraph

Article in Inflammatory intestinal diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Talia AzadShifa International Hospital, Islamabad, Pakistan.
Junaid MushtaqDoctors Hospital, Lahore, Pakistan.
Ghias Un-Nabi TayyabDoctors Hospital, Lahore, Pakistan.
Om ParkashAga Khan University Hospital, Karachi, Pakistan.
Maliha AzizShifa International Hospital, Islamabad, Pakistan.
Tauseef AliSSM Health Crohn's and Colitis Center, Oklahoma City, OK, USA.
Muhammad UmairNowshera Medical College, Nowshera, Pakistan.
Ali Syed GillaniShifa College of Medicine, Islamabad, Pakistan.
Muslim AtiqShifa International Hospital, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The incidence and prevalence of inflammatory bowel disease (IBD) are increasing in South Asia, including Pakistan. Biologic therapies have transformed IBD management; however, physician confidence in initiating these therapies and real-world prescribing patterns remain variable. Methods: A cross-sectional survey was conducted among physicians involved in IBD care across Pakistan using an online questionnaire. A total of 100 physicians were invited to participate; 99 respondents with complete data were included in the analysis. The survey assessed demographics, training background, practice setting, therapeutic preferences, physician-reported confidence in initiating biologic therapy, and perceived barriers. Descriptive statistics and comparative analyses were performed. Results: Most respondents were male (83.8%), with the largest age group being 35-44 years (43.4%). Most participants had completed formal gastroenterology training (87.9%), with 17.2% reporting overseas training. Overseas training was significantly associated with greater confidence in initiating biologic therapy for UC induction ( Conclusion: Physician confidence in initiating biologic therapy for IBD in Pakistan is associated with training exposure and therapeutic approach. Addressing barriers such as infection screening, cost, and access, along with strengthening IBD-focused training programs, may support more consistent and guideline-concordant care.

Indexed as

Anti-TNFBiologicsCrohn’s diseaseInflammatory bowel diseasePakistanSouth AsiaTherapeutic strategyUlcerative colitis

Identifiers

PMID42598667
PMCPMC13472612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.